Glucose-6-phosphate dehydrogenase modulates vascular endothelial growth factor-mediated angiogenesis
Discontinued formulations Efpeglenatide and taspoglutide Efpeglenatide and taspoglutide were once-promising, long-acting GLP-1 receptor agonists developed for the treatment of T2DM, both designed for once-weekly administration
Sodium-Glucose Co-Transporter-2 Inhibitors Sodium-glucose co-transporter-2 (SGLT-2) inhibitors are currently licensed for the treatment of T2D, though there is a growing body of evidence to support their use in cardiovascular [56] and renal disease [57]
There are days when youre brushing your hair slowly, lost in the usual swarm of thoughts, and then suddenly you spot it - a strand that looks different, a colour that doesnt belong with the rest
Whether through evidence-based clinical therapies, medication-assisted treatment including approaches like Suboxone and Sublocade for opioid dependence or emerging interventions informed by research like this, our goal is to give every individual the most effective path forward
Can act as an antioxidant, decreasing free radical formation caused by UV radiation
